GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Incyte Corporation (INCY) [hlAlert]

Rating:
Buy INCY
up 69.26 %

Incyte Corporation (INCY) rated Buy with price target $84 by BofA/Merrill

Posted on: Wednesday,  Feb 26, 2014  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Incyte Corporation (NASDAQ: INCY) on 02/26/2014, when the stock price was $67.26. Since
then, Incyte Corporation has gained 69.27% as of 01/14/2016's recent price of $113.85.
If you would have followed this BofA/Merrill's recommendation on INCY, you would have gained 69.26% of your investment in 687 days.

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation and diabetes. Incyte?s pipeline includes compounds in various stages of development in the areas of oncology, inflammation, diabetes and human immunodeficiency virus (HIV).

BofA/Merrill
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/26/2014 8:25 AM Buy
None
67.26 84.00
as of 10/17/2014
1 Week up  8.63 %
1 Month up  3.77 %
3 Months up  10.42 %
1 YTD down  -25.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy